source
- Overseas MDMA and psilocybin makers eye U.S. market as regulatory landscape easesCompanies that produce MDMA and psilocybin for patients abroad are turning their attention to the United States, hoping to leverage experience gained under more permissive foreign rules. Rising pol…
- Opinion: U.S., U.K. health care systems share a fatal flaw“The default to biomedical responses means that clinics and hospitals are increasingly absorbing the costs of social problems,” writes Kyle Vanelli.STAT · 55m ago↗ source
- Two years after rules overhaul, have methadone clinics really changed?